Newsroom

Mar 14, 2024 MDx Zepto Life Technology Showcase at European Congress of Clinical Microbiology and Infectious Disease Conference Presented with Mayo Clinic in Barcelona, the study details a multiplex GMR and lab-on-a-chip assay for invasive fungal infection diagnosis. → Feb 14, 2024 Team Zepto Life Technology Builds Medical & Technical Advisory Board MTAB A distinguished board of infectious disease, cfDNA, and regulatory experts is formed to guide Zepto's scientific direction. → Jan 14, 2024 MDx Zepto Life Technology Showcase at Advances Against Aspergillosis Conference Presented in Milan, the abstract details detection of Aspergillus fumigatus cell-free DNA using GMR technology. → Dec 14, 2023 Investors Zepto Life Technology Closes Series A Funding The round funds fabrication and testing of a fully integrated system automating the assay workflow from sample to result. → Nov 14, 2023 FungiFlex Zepto's Innovative Invasive Fungal Infection (IFI) Detection System Study Launch A collaboration with the University of Minnesota puts Zepto's primer and probe design and GMR detection to the test in clinical molecular diagnostics. → Feb 14, 2023 FungiFlex Zepto Life Launches Pilot Clinical Study with Mayo Clinic for Invasive Fungal Infection Detection Led by Dr. Vergidis, the study evaluates Zepto's diagnostic test for invasive fungal infections directly from patient blood samples. →